Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 9/2017

30.06.2017 | Retinal Disorders

Is ellipsoid zone integrity essential for visual recovery in myopic neovascularization after anti-VEGF therapy?

verfasst von: Paolo Milani, Marco Pellegrini, Amedeo Massacesi, Stefania Moschini, Marco Setaccioli, Davide Soranna, Antonella Zambon, Ferdinando Bottoni, Fulvio Bergamini

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate functional prognostic factors and neuroretinal changes after anti-vascular endothelial growth factor (VEGF) treatment in patients with naïve, recent myopic neovascularization (mCNV), as assessed by spectral-domain optical coherence tomography (SD-OCT).

Methods

Specific changes in tomographic features between baseline and final follow-up were retrospectively evaluated by two examiners independently. Imaging was obtained by a multi-modal imaging system which combines fluorescein angiography and SD-OCT.

Results

Twenty-two eyes (male, six; female, 16; mean age, 65 ± 14 years) were considered. Mean follow-up was 21.5 ± 14 months. Best-corrected visual acuity (BCVA) improved from 0.38 ± 0.26 to 0.16 ± 0.20 logMAR (p < 0.001). The ellipsoid zone and the external limiting membrane (ELM) were disrupted in 21 (95.5%) and 15 (68.2%) eyes at baseline, and in 16 (72.7%) and nine (40.9%) eyes after therapy respectively. The ellipsoid zone and ELM were typically intact at lesion margins in 13 (59.1%) and 19 eyes (86.5%) respectively at baseline. The inner retina was intact in 20 eyes (91%). Six eyes (27.3%) exhibited complete regression without fibrosis. Absence of hemorrhage and integrity of lesion-adjacent ELM and of lesion-adjacent ellipsoid zone at baseline were factors for better final BCVA (p ≤ 0.05)

Conclusion

Vision gain might occur despite ellipsoid zone or ELM restoration. Hemorrhage could be considered a negative prognostic factor, integrity of lesion-adjacent ELM and of lesion-adjacent ellipsoid zone as positive prognostic factors. Myopic CNV can also resolve completely without fibrosis.
Literatur
1.
Zurück zum Zitat Freund KB, Zweifel SA, Engelbert M (2010) Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina 30:1333–1349CrossRefPubMed Freund KB, Zweifel SA, Engelbert M (2010) Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina 30:1333–1349CrossRefPubMed
2.
Zurück zum Zitat Keane PA, Liakopoulos S, Chang KT, Heussen FM, Ongchin SC, Walsh AC, Sadda SR (2008) Comparison of the optical coherence tomographic features of choroidal neovascular membranes in pathological myopia versus age-related macular degeneration, using quantitative subanalysis. Br J Ophthalmol 92:1081–1085CrossRefPubMedPubMedCentral Keane PA, Liakopoulos S, Chang KT, Heussen FM, Ongchin SC, Walsh AC, Sadda SR (2008) Comparison of the optical coherence tomographic features of choroidal neovascular membranes in pathological myopia versus age-related macular degeneration, using quantitative subanalysis. Br J Ophthalmol 92:1081–1085CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Wang E, Chen Y (2013) Intravitreal anti-vascular endothelial growth factor for choroidal neovascularization secondary to pathologic myopia: systematic review and meta-analysis. Retina 33:1375–1392CrossRefPubMed Wang E, Chen Y (2013) Intravitreal anti-vascular endothelial growth factor for choroidal neovascularization secondary to pathologic myopia: systematic review and meta-analysis. Retina 33:1375–1392CrossRefPubMed
4.
Zurück zum Zitat Wong TY, Ferreira A, Hughes R et al (2014) Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review. Am J Ophthalmol 157:9–25CrossRefPubMed Wong TY, Ferreira A, Hughes R et al (2014) Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review. Am J Ophthalmol 157:9–25CrossRefPubMed
5.
Zurück zum Zitat Freitas-da-Costa P, Pinheiro-Costa J, Carvalho B, Falcão M, Brandão E, Falcão-Reis F, Carneiro  (2014) Anti-VEGF therapy in myopic choroidal neovascularization: long-term results. Ophthalmologica 232:57–63CrossRefPubMed Freitas-da-Costa P, Pinheiro-Costa J, Carvalho B, Falcão M, Brandão E, Falcão-Reis F, Carneiro  (2014) Anti-VEGF therapy in myopic choroidal neovascularization: long-term results. Ophthalmologica 232:57–63CrossRefPubMed
6.
Zurück zum Zitat Ng DS, Kwok AK, Chan CW (2012) Anti-vascular endothelial growth factor for myopic choroidal neovascularization. Clin Experiment Ophthalmol 40:e98–e110CrossRefPubMed Ng DS, Kwok AK, Chan CW (2012) Anti-vascular endothelial growth factor for myopic choroidal neovascularization. Clin Experiment Ophthalmol 40:e98–e110CrossRefPubMed
7.
Zurück zum Zitat Ikuno Y, Ohno-Matsui K, Wong TY, Korobelnik JF, Vitti R, Li T, Stemper B, Asmus F, Zeitz O, Ishibashi T, MYRROR Investigators (2015) Intravitreal aflibercept injection in patients with myopic choroidal neovascularization: the MYRROR study. Ophthalmology 122:1220–1227CrossRefPubMed Ikuno Y, Ohno-Matsui K, Wong TY, Korobelnik JF, Vitti R, Li T, Stemper B, Asmus F, Zeitz O, Ishibashi T, MYRROR Investigators (2015) Intravitreal aflibercept injection in patients with myopic choroidal neovascularization: the MYRROR study. Ophthalmology 122:1220–1227CrossRefPubMed
8.
Zurück zum Zitat Baba T, Ohno-Matsui K, Yoshida T et al (2002) Optical coherence tomography of choroidal neovascularization in high myopia. Acta Ophthalmol Scand 80:82–87CrossRefPubMed Baba T, Ohno-Matsui K, Yoshida T et al (2002) Optical coherence tomography of choroidal neovascularization in high myopia. Acta Ophthalmol Scand 80:82–87CrossRefPubMed
9.
Zurück zum Zitat Milani P, Pece A, Pierro L, Bergamini F (2014) Imaging of naive myopic choroidal neovascularization by spectral-domain optical coherence tomography. Ophthalmologica 232:28–36CrossRefPubMed Milani P, Pece A, Pierro L, Bergamini F (2014) Imaging of naive myopic choroidal neovascularization by spectral-domain optical coherence tomography. Ophthalmologica 232:28–36CrossRefPubMed
10.
Zurück zum Zitat Introini U, Casalino G, Querques G, Gimeno AT, Scotti F, Bandello F (2012) Spectral-domain OCT in anti-VEGF treatment of myopic choroidal neovascularization. Eye (Lond) 26:976–982CrossRef Introini U, Casalino G, Querques G, Gimeno AT, Scotti F, Bandello F (2012) Spectral-domain OCT in anti-VEGF treatment of myopic choroidal neovascularization. Eye (Lond) 26:976–982CrossRef
11.
Zurück zum Zitat Bruyère E, Caillaux V, Cohen SY, Martiano D, Ores R, Puche N, Souied EH (2015) Spectral-domain optical coherence tomography of subretinal hyperreflective exudation in myopic choroidal neovascularization. Am J Ophthalmol 160:749–758CrossRefPubMed Bruyère E, Caillaux V, Cohen SY, Martiano D, Ores R, Puche N, Souied EH (2015) Spectral-domain optical coherence tomography of subretinal hyperreflective exudation in myopic choroidal neovascularization. Am J Ophthalmol 160:749–758CrossRefPubMed
12.
Zurück zum Zitat Battaglia Parodi M, Iacono P, Bandello F (2016) Correspondence of leakage on fluorescein angiography and optical coherence tomography parameters in diagnosis and monitoring of myopic choroidal neovascularization treated with bevacizumab. Retina 36:104–109CrossRefPubMed Battaglia Parodi M, Iacono P, Bandello F (2016) Correspondence of leakage on fluorescein angiography and optical coherence tomography parameters in diagnosis and monitoring of myopic choroidal neovascularization treated with bevacizumab. Retina 36:104–109CrossRefPubMed
13.
Zurück zum Zitat Mathew R, Richardson M, Sivaprasad S (2013) Predictive value of spectral-domain optical coherence tomography features in assessment of visual prognosis in eyes with neovascular age-related macular degeneration treated with ranibizumab. Am J Ophthalmol 155:720–726CrossRefPubMed Mathew R, Richardson M, Sivaprasad S (2013) Predictive value of spectral-domain optical coherence tomography features in assessment of visual prognosis in eyes with neovascular age-related macular degeneration treated with ranibizumab. Am J Ophthalmol 155:720–726CrossRefPubMed
14.
Zurück zum Zitat Sayanagi K, Sharma S, Kaiser PK (2009) Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration. Br J Ophthalmol 93:622–626CrossRefPubMed Sayanagi K, Sharma S, Kaiser PK (2009) Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration. Br J Ophthalmol 93:622–626CrossRefPubMed
15.
Zurück zum Zitat Ota M, Tsujikawa A, Kita M et al (2008) Integrity of foveal photoreceptor layer in central retinal vein occlusion. Retina 28:1502–1508CrossRefPubMed Ota M, Tsujikawa A, Kita M et al (2008) Integrity of foveal photoreceptor layer in central retinal vein occlusion. Retina 28:1502–1508CrossRefPubMed
16.
Zurück zum Zitat Murakami T, Nishijima K, Sakamoto A, Ota M, Horii T, Yoshimura N (2011) Association of pathomorphology, photoreceptor status, and retinal thickness with visual acuity in diabetic retinopathy. Am J Ophthalmol 151:310–317CrossRefPubMed Murakami T, Nishijima K, Sakamoto A, Ota M, Horii T, Yoshimura N (2011) Association of pathomorphology, photoreceptor status, and retinal thickness with visual acuity in diabetic retinopathy. Am J Ophthalmol 151:310–317CrossRefPubMed
17.
Zurück zum Zitat Bottoni F, De Angelis S, Luccarelli S, Cigada M, Staurenghi G (2011) The dynamic healing process of idiopathic macular holes after surgical repair: a spectral-domain optical coherence tomography study. Invest Ophthalmol Vis Sci 52:4439–4446CrossRefPubMed Bottoni F, De Angelis S, Luccarelli S, Cigada M, Staurenghi G (2011) The dynamic healing process of idiopathic macular holes after surgical repair: a spectral-domain optical coherence tomography study. Invest Ophthalmol Vis Sci 52:4439–4446CrossRefPubMed
18.
Zurück zum Zitat Stanescu-Segall D, Balta F, Jackson TL (2018) Submacular hemorrhage in neovascular age-related macular degeneration: a synthesis of the literature. Surv Ophthalmol 61:18–32CrossRef Stanescu-Segall D, Balta F, Jackson TL (2018) Submacular hemorrhage in neovascular age-related macular degeneration: a synthesis of the literature. Surv Ophthalmol 61:18–32CrossRef
19.
Zurück zum Zitat Asai T, Ikuno Y, Nishida K (2014) Macular microstructures and prognostic factors in myopic subretinal hemorrhages. Invest Ophthalmol Vis Sci 55:226–232CrossRefPubMed Asai T, Ikuno Y, Nishida K (2014) Macular microstructures and prognostic factors in myopic subretinal hemorrhages. Invest Ophthalmol Vis Sci 55:226–232CrossRefPubMed
20.
Zurück zum Zitat Framme C, Wolf S, Wolf-Schnurrbusch U (2010) Small dense particles in the retina observable by spectral-domain optical coherence tomography in age-related macular degeneration. Invest Ophthalmol Vis Sci 51:5965–5969CrossRefPubMed Framme C, Wolf S, Wolf-Schnurrbusch U (2010) Small dense particles in the retina observable by spectral-domain optical coherence tomography in age-related macular degeneration. Invest Ophthalmol Vis Sci 51:5965–5969CrossRefPubMed
21.
Zurück zum Zitat Bolz M, Schmidt-Erfurth U, Deak G, Mylonas G, Kriechbaum K, Scholda C (2009) Diabetic retinopathy research group Vienna: optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology 116:914–920CrossRefPubMed Bolz M, Schmidt-Erfurth U, Deak G, Mylonas G, Kriechbaum K, Scholda C (2009) Diabetic retinopathy research group Vienna: optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology 116:914–920CrossRefPubMed
22.
Zurück zum Zitat AbriAghdam K, Pielen A, Framme C, Junker B (2015) Correlation between Hyperreflective foci and clinical outcomes in Neovascular age-related macular degeneration after switching to aflibercept. Invest Ophthalmol Vis Sci 56:6448–6455CrossRef AbriAghdam K, Pielen A, Framme C, Junker B (2015) Correlation between Hyperreflective foci and clinical outcomes in Neovascular age-related macular degeneration after switching to aflibercept. Invest Ophthalmol Vis Sci 56:6448–6455CrossRef
23.
Zurück zum Zitat De Benedetto U, Sacconi R, Pierro L, Lattanzio R, Bandello F (2015) Optical coherence tomographic hyperreflective foci in early stages of diabetic retinopathy. Retina 35:449–453CrossRefPubMed De Benedetto U, Sacconi R, Pierro L, Lattanzio R, Bandello F (2015) Optical coherence tomographic hyperreflective foci in early stages of diabetic retinopathy. Retina 35:449–453CrossRefPubMed
24.
Zurück zum Zitat Parodi MB, Da Pozzo S, Ravalico G (2007) Retinal pigment epithelium changes after photodynamic therapy for choroidal neovascularization in pathological myopia. Acta Ophthalmol Scand 85:50–54CrossRefPubMed Parodi MB, Da Pozzo S, Ravalico G (2007) Retinal pigment epithelium changes after photodynamic therapy for choroidal neovascularization in pathological myopia. Acta Ophthalmol Scand 85:50–54CrossRefPubMed
25.
Zurück zum Zitat Miller H, Miller B, Ryan SJ (1986) The role of retinal pigment epithelium in the involution of subretinal neovascularisation. Invest Ophthalmol Vis Sci 27:1644–1652PubMed Miller H, Miller B, Ryan SJ (1986) The role of retinal pigment epithelium in the involution of subretinal neovascularisation. Invest Ophthalmol Vis Sci 27:1644–1652PubMed
Metadaten
Titel
Is ellipsoid zone integrity essential for visual recovery in myopic neovascularization after anti-VEGF therapy?
verfasst von
Paolo Milani
Marco Pellegrini
Amedeo Massacesi
Stefania Moschini
Marco Setaccioli
Davide Soranna
Antonella Zambon
Ferdinando Bottoni
Fulvio Bergamini
Publikationsdatum
30.06.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 9/2017
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-017-3706-x

Weitere Artikel der Ausgabe 9/2017

Graefe's Archive for Clinical and Experimental Ophthalmology 9/2017 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.